Groundbreaking Cancer Treatment Developed By This Biotech Company

Groundbreaking Progress in Cancer Treatment: TransCode Therapeutics' TTX-MC138 Shows Promising Results.

In the relentless pursuit of effective cancer treatments, a leading biotechnology company, TransCode Therapeutics, has made significant strides with their lead therapeutic candidate, TTX-MC138. This revolutionary treatment solution is specific to metastatic disease, an area traditionally challenging to tackle.

TTX-MC138 is part of TransCode's investigati…